NO161067C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive (1h-tetrazol-5-yl)-tetrazol(1,5-a)-kinoliner og (1h-tetrazol-5-yl)-tetrazol(1,5-a)(1,8)naftyridiner. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive (1h-tetrazol-5-yl)-tetrazol(1,5-a)-kinoliner og (1h-tetrazol-5-yl)-tetrazol(1,5-a)(1,8)naftyridiner.Info
- Publication number
- NO161067C NO161067C NO841156A NO841156A NO161067C NO 161067 C NO161067 C NO 161067C NO 841156 A NO841156 A NO 841156A NO 841156 A NO841156 A NO 841156A NO 161067 C NO161067 C NO 161067C
- Authority
- NO
- Norway
- Prior art keywords
- tetrazol
- kinolines
- naphthyridines
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/478,964 US4496569A (en) | 1983-03-25 | 1983-03-25 | Antiallergic (1H-tetrazol-5-yl)tetrazolo[1,5-a]quinolines and derivatives thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO841156L NO841156L (no) | 1984-09-26 |
| NO161067B NO161067B (no) | 1989-03-20 |
| NO161067C true NO161067C (no) | 1989-06-28 |
Family
ID=23902115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO841156A NO161067C (no) | 1983-03-25 | 1984-03-23 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive (1h-tetrazol-5-yl)-tetrazol(1,5-a)-kinoliner og (1h-tetrazol-5-yl)-tetrazol(1,5-a)(1,8)naftyridiner. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4496569A (da) |
| EP (1) | EP0120484B1 (da) |
| JP (1) | JPS59176287A (da) |
| KR (1) | KR900003649B1 (da) |
| AT (1) | ATE26717T1 (da) |
| AU (1) | AU558762B2 (da) |
| CA (1) | CA1252100A (da) |
| DE (1) | DE3463271D1 (da) |
| DK (1) | DK165694C (da) |
| ES (1) | ES8601970A1 (da) |
| GR (1) | GR81463B (da) |
| IE (1) | IE57072B1 (da) |
| IL (1) | IL71318A (da) |
| MX (1) | MX9203341A (da) |
| NO (1) | NO161067C (da) |
| NZ (1) | NZ207582A (da) |
| PH (1) | PH20353A (da) |
| PT (1) | PT78288B (da) |
| ZA (1) | ZA842067B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4014171A1 (de) * | 1990-05-03 | 1991-11-07 | Basf Ag | Cyanochinolinverbindungen |
| WO1995026348A1 (en) * | 1994-03-25 | 1995-10-05 | Merrell Dow Pharmaceuticals Inc. | PROCESS FOR PREPARING (1H-TETRAZOL-5-yl)TETRAZOLO [1,5-a] QUINOLINES AND NAPHTHYRIDINES |
| JP3674407B2 (ja) | 1999-09-21 | 2005-07-20 | ヤマハ株式会社 | 演奏データ編集装置、方法及び記録媒体 |
| JP2007506788A (ja) * | 2003-09-26 | 2007-03-22 | ライジェル ファーマシューティカルズ， インコーポレイテッド | Ｈｃｖ感染阻害剤とその使用法 |
| US7569580B2 (en) | 2004-06-03 | 2009-08-04 | Rigel Pharmaceuticals, Inc. | Heterotricyclic compounds for use as HCV inhibitors |
| KR101101950B1 (ko) * | 2011-11-04 | 2012-01-02 | 이동진 | 왕복 페달식 자전거 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3764681A (en) * | 1970-07-08 | 1973-10-09 | Lilly Co Eli | Certain tetrazolo-(1,5-a) quinoline compounds as fungus control agents |
| US4035368A (en) * | 1975-04-02 | 1977-07-12 | Riker Laboratories, Inc. | Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds |
-
1983
- 1983-03-25 US US06/478,964 patent/US4496569A/en not_active Expired - Lifetime
-
1984
- 1984-03-20 ZA ZA842067A patent/ZA842067B/xx unknown
- 1984-03-20 CA CA000449960A patent/CA1252100A/en not_active Expired
- 1984-03-21 NZ NZ207582A patent/NZ207582A/en unknown
- 1984-03-21 AU AU25953/84A patent/AU558762B2/en not_active Ceased
- 1984-03-21 GR GR74165A patent/GR81463B/el unknown
- 1984-03-21 PT PT78288A patent/PT78288B/pt not_active IP Right Cessation
- 1984-03-22 PH PH30426A patent/PH20353A/en unknown
- 1984-03-22 JP JP59053690A patent/JPS59176287A/ja active Granted
- 1984-03-22 IL IL71318A patent/IL71318A/xx not_active IP Right Cessation
- 1984-03-22 ES ES530876A patent/ES8601970A1/es not_active Expired
- 1984-03-23 IE IE719/84A patent/IE57072B1/en not_active IP Right Cessation
- 1984-03-23 DK DK165584A patent/DK165694C/da not_active IP Right Cessation
- 1984-03-23 EP EP84103232A patent/EP0120484B1/en not_active Expired
- 1984-03-23 NO NO841156A patent/NO161067C/no unknown
- 1984-03-23 KR KR1019840001504A patent/KR900003649B1/ko not_active IP Right Cessation
- 1984-03-23 DE DE8484103232T patent/DE3463271D1/de not_active Expired
- 1984-03-23 AT AT84103232T patent/ATE26717T1/de not_active IP Right Cessation
-
1992
- 1992-06-25 MX MX9203341A patent/MX9203341A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU558762B2 (en) | 1987-02-05 |
| KR840008156A (ko) | 1984-12-13 |
| DK165694C (da) | 1993-06-07 |
| ES530876A0 (es) | 1985-11-01 |
| IE57072B1 (en) | 1992-04-22 |
| EP0120484A1 (en) | 1984-10-03 |
| IL71318A0 (en) | 1984-06-29 |
| PT78288B (en) | 1986-04-22 |
| DK165584D0 (da) | 1984-03-23 |
| PH20353A (en) | 1986-12-04 |
| JPS59176287A (ja) | 1984-10-05 |
| ES8601970A1 (es) | 1985-11-01 |
| GR81463B (da) | 1984-12-11 |
| ATE26717T1 (de) | 1987-05-15 |
| DK165584A (da) | 1984-09-26 |
| AU2595384A (en) | 1984-09-27 |
| MX9203341A (es) | 1992-08-01 |
| PT78288A (en) | 1984-04-01 |
| IE840719L (en) | 1984-09-25 |
| NO161067B (no) | 1989-03-20 |
| KR900003649B1 (ko) | 1990-05-28 |
| EP0120484B1 (en) | 1987-04-22 |
| NZ207582A (en) | 1986-10-08 |
| IL71318A (en) | 1986-11-30 |
| DK165694B (da) | 1993-01-04 |
| CA1252100A (en) | 1989-04-04 |
| US4496569A (en) | 1985-01-29 |
| NO841156L (no) | 1984-09-26 |
| DE3463271D1 (en) | 1987-05-27 |
| ZA842067B (en) | 1984-10-31 |
| JPH0415791B2 (da) | 1992-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO155622C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido- og isokinolin (1[,2[:1,2) imidazo (5,4-c) rifamycin sv og s derivater. | |
| NO174508C (da) | ||
| DK306884A (da) | (3-amino-1h-pyrazol-4-yl)-(aryl)methanoner og fremgangsmaade til deres fremstilling | |
| NO161067C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive (1h-tetrazol-5-yl)-tetrazol(1,5-a)-kinoliner og (1h-tetrazol-5-yl)-tetrazol(1,5-a)(1,8)naftyridiner. | |
| PT78289A (en) | (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds | |
| IE831145L (en) | Pyridine derivatives | |
| HU908400D0 (en) | Process for the production of imidazo(4,5-c)pyridine derivatives and medical preparations containing these compounds as active agents | |
| NO167573C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r, 6s,)-6-((r)-1-hydroksyetyl)-2-azacykloalkyltio-2-penem-3-karboksyl-syrederivater. | |
| NO155773C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte tetrahydropyrrolo (1,2-a) pyrimidinderivater. | |
| NO160142C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2,4)triazolo(4,3-a)kinoksalin-4-amin-derivater. | |
| SE8400118D0 (sv) | Substituted carboxy-thiazolo(3,2-a)pyrimidine derivatives and process for their preparation | |
| DK69886A (da) | Substituerede phenoxypropylthiopyrazolo(1,5-a)pyridin- eller -benzimidazolderivater, fremgangsmaade til fremstilling deraf og antiallergisk middel indeholdende saadanne forbindelser | |
| AU553493B2 (en) | 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives | |
| NO166128C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(1,2-a)pyridinderivater. | |
| DE3576076D1 (de) | (tetrazolyl)thienopyridone. |